1 story in the last 7 days
The latest firefly bio news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks firefly bio across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Johnson & Johnson agreed to acquire Firefly Bio, a privately held biotechnology startup, for $1 billion in cash. Firefly's crown jewel is a single piece of technology aimed at hard-to-treat cancers. The deal pumps fresh cash into one of the most watched sectors in health care.
Summaries by ByteBrief